April 1, 2026

McDermott Will & Schulte deepens private equity restructuring bench with arrival of Gregg Galardi

April 1, 2026

McDermott Will & Schulte expands funds platform with return of Cerberus COO of asset-backed opportunities

April 1, 2026

McDermott Will & Schulte shortlisted for Healthcare & Life Sciences Law Firm of the Year at Chambers USA Awards 2026

April 1, 2026

McDermott Will & Schulte shortlisted for four LMG Life Sciences EMEA Awards 2026

March 31, 2026

McDermott Will & Schulte recognized in Global Arbitration Review’s GAR 100 2026

March 20, 2026

LME in Europe: Advantages, limitations and prospects

March 26, 2026

BlockFills gets Ch. 11 stay of crypto suit targeting 3 execs

March 26, 2026

McDermott advises on sale of Rotron Aerospace Ltd to Ondas Inc

March 26, 2026

McDermott Will & Schulte named Pharma/Life Sciences Law Firm of the Year at Chambers France Awards 2026

March 20, 2026

Trends for 2026: Between the broadening impact of business failures across sectors and the strengths of French law

March 25, 2026

McDermott Will & Schulte recognized in Legal 500 EMEA 2026

March 25, 2026

McDermott advises Würth Elektronik ICS on the acquisition of MRS Electronic

March 24, 2026

McDermott advises Purflux Filtration S.A, a portfolio company of Pacific Avenue Capital on financings

March 24, 2026

McDermott Will & Schulte advises Doral Renewables in its financing and tax credit monetization of the Cold Creek Solar + Storage Project

March 20, 2026

Screening of foreign investments in the EU: What impact on funds?

March 17, 2026

What happens when a sale is not an option…affiliate.

March 19, 2026

McDermott Will & Schulte advises Inverness Graham in its acquisition of Axcel Learning

March 19, 2026

McDermott Will & Schulte advises Owkin on the carve-out of Waiv and its $33 million financing